Page last updated: 2024-10-19

lipoamide and Diabetes Mellitus, Type 2

lipoamide has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Lipozyme: lipase from Rhizomucor miehei immobilized on anion exchange resin

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, HF1
Liu, HM1
Xiang, JY1
Zhou, XC1
Wang, D1
Chen, RY1
Tan, WL1
Liang, LQ1
Liu, LL1
Shi, MJ1
Zhang, F1
Xiao, Y1
Zhou, YX1
Zhang, T1
Tang, L1
Guo, B1
Wang, YY1

Other Studies

1 other study available for lipoamide and Diabetes Mellitus, Type 2

ArticleYear
Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:5

    Topics: Animals; beta Catenin; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus, Type

2023